Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of cancer cell death induction by paclitaxel: an updated review
Shuang Zhao, Yufei Tang, Ruohan Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 9-10, pp. 647-667
Closed Access | Times Cited: 102

Showing 26-50 of 102 citing articles:

Investigation of the sensitivity of human A549 cells to paclitaxel and sesquiterpene lactone alantolactone via apoptosis induction
İrem BAYAR, Yalçın Erzurumlu, Senem Akkoç, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies
Giovanni Luca Beretta, Giuliana Cassinelli, Giacomina Rossi, et al.
Drug Resistance Updates (2025), pp. 101223-101223
Open Access
Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis
Alessia Salzillo, Angela Ragone, Annamaria Spina, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151292-151292
Open Access | Times Cited: 14
Mechanisms of cancer cell death induction by triptolide
Ali Hamid AbdulHussein, Muataz Mohammed Al‐Taee, Zahra Abdul Radih, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 718-735
Closed Access | Times Cited: 12
Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
Daniel Barriuso, Lucia Alvarez-Frutos, Lucía G. Gutiérrez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6374-6374
Open Access | Times Cited: 12
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance
Bifei Fu, YuMing Lou, Pu Wu, et al.
Neoplasia (2024) Vol. 55, pp. 101017-101017
Open Access | Times Cited: 4
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 10
Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials
Yunshu Liao, Qinghua Meng
Environmental Research (2023) Vol. 238, pp. 116896-116896
Closed Access | Times Cited: 10
Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
Jesse Demuytere, Charlotte Carlier, Leen Van de Sande, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 429-440
Open Access | Times Cited: 3
Sonic hedgehog restrains the ubiquitin-dependent degradation of SP1 to inhibit neuronal/glial senescence associated phenotypes in chemotherapy-induced peripheral neuropathy via the TRIM25-CXCL13 axis
Ying Zou, Shu Wu, Qian Hu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis
Zi-qiong Wang, Zhixuan Wu, Zong-pan Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles
Chou‐Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155266-155266
Closed Access | Times Cited: 3
Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer
Xin Li, Wencai Guan, Huiqiang Liu, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1546-1563
Open Access | Times Cited: 3
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 3
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond
Martina Minisini, Massimo Mascaro, Claudio Brancolini
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations
Karine Normandin, Jasmin Coulombe‐Huntington, Corinne St‐Denis, et al.
PLoS Genetics (2023) Vol. 19, Iss. 8, pp. e1010903-e1010903
Open Access | Times Cited: 9
Paclitaxel promotes mTOR signaling‐mediated apoptosis in esophageal cancer cells by targeting MUC20
Meng Li, Zhen Feng, Rui Han, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 31, pp. 3089-3096
Open Access | Times Cited: 8
Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 2
Phytochemicals and Their Nanoformulations for Targeting Hepatocellular Carcinoma: Exploring Potential and Targeting Strategies
Safia Obaidur Rab, R. Roopashree, Farag M. A. Altalbawy, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 2
LncRNAs in modulating cancer cell resistance to paclitaxel (PTX) therapy
Ali G. Alkhathami, Harikumar Pallathadka, Sejal Shah, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 2
Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis
Kuan‐Hung Lin, Jiun-Yi Li, Ray‐Jade Chen, et al.
Thrombosis Research (2023) Vol. 225, pp. 63-72
Closed Access | Times Cited: 7
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Ketao Li, Wan Chen, Liping Ma, et al.
Environmental Research (2023) Vol. 244, pp. 117264-117264
Closed Access | Times Cited: 7
Targeting the oral tumor microenvironment by nanoparticles: A review of progresses
Haosheng Zhang, Fangzheng Zhou, Qiuyu Yang, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105248-105248
Closed Access | Times Cited: 7
Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy
Nayeon Shim, Hanhee Cho, Seong Ik Jeon, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 54, Iss. 1, pp. 13-36
Closed Access | Times Cited: 6
Paclitaxel induces pyroptosis by inhibiting the volume‑sensitive chloride channel leucine‑rich repeat‑containing 8a in ovarian cancer cells
Xiurou Xiurou, Chao Chao, Xuzhen Liao, et al.
Oncology Reports (2023) Vol. 49, Iss. 6
Open Access | Times Cited: 5

Scroll to top